StockData
Odyssey Therapeutics, Inc. logo

Odyssey Therapeutics, Inc. (ODTX) shareholders

ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$19.37+0.01 (+0.05%)

Close on Nov 17, 2026Market cap $930.89MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
72.4%
35M of 48M shares
Institutional holders
58
58 new, 0 sold out
Net institutional buying
35M
In Q2 2026
Insider trades, 12 months
9 buys · 3 sales
Net bought $75.29M

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
FMR LLC
Joint filing with Abigail P. Johnson (13.00%)
6,239,23713.00%13G (passive) amendmentSep 30, 2026
SR One Capital Management, LLC
Joint filing with Simeon George (8.00%)
3,794,8838.00%13D (active)May 11, 2026
Tpg Gp A, LLC
Joint filing with James G. Coulter (7.80%), Jon Winkelried (7.80%)
3,690,1467.80%13D (active)May 11, 2026
Jeito II S.L.P.
Joint filing with Jeito Capital SAS (7.80%), Rafaele Tordjman (7.80%) and 1 more
3,690,1457.80%13D (active)May 8, 2026
Lightspeed General Partner XV-B (Ignite), L.P.
Joint filing with Lightspeed Venture Partners XV-B (Ignite), L.P. (7.60%), Lightspeed Ultimate General Partner XV-B (Ignite), L.L.C. (7.60%)
3,608,4437.60%13G (passive)May 11, 2026
Nan Li
Joint filing with Dimension Management, L.P. (7.10%), Dimension Capital II, L.P. (7.10%) and 4 more
3,333,5167.10%13D (active)May 8, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ODTXValueChange% of portfolio
FMR LLC5,179,26210.78%$96.90MNew0.00%
Sr One Capital Management, LP3,794,8837.90%$71.00MNew6.83%
Tpg Gp A, LLC3,690,1467.68%$69.04MNew1.38%
Lightspeed Management Company, L.L.C.3,608,4437.51%$67.51MNew2.81%
Orbimed Advisors LLC3,001,1986.24%$56.15MNew1.04%
Sanofi1,991,9184.14%$37.27MNew6.98%
Deerfield Management Company, L.P. (Series C)1,046,1392.18%$19.57MNew0.20%
Sands Capital Ventures, LLC875,0001.82%$16.37MNew2.67%
Hhlr Advisors, Ltd.831,6561.73%$15.56MNew1.87%
General Catalyst Group Management, LLC810,2721.69%$15.16MNew8.04%
Affinity Asset Advisors, LLC766,3461.59%$14.34MNew0.65%
Adage Capital Partners Gp, L.L.C.725,0001.51%$13.56MNew0.02%
Vanguard Capital Management LLC720,4401.50%$13.48MNew0.00%
Foresite Capital Management V, LLC713,1051.48%$13.34MNew3.68%
Vivo Capital, LLC575,0001.20%$10.76MNew0.98%
EcoR1 Capital, LLC555,5551.16%$10.39MNew0.51%
Logos Global Management LP521,7361.09%$9.76MNew0.42%
Marshall Wace, Llp492,6971.03%$9.22MNew0.01%
Price T Rowe Associates Inc /Md/471,9870.98%$8.83MNew0.00%
Catalio Capital Management, LP457,8390.95%$8.57MNew1.61%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20265835M72.4%58 / 00 / 035M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of ODTXValue% of fundAs of
Fidelity Growth Company Fund595,9001.24%$10.14M0.01%May 31, 2026
Vanguard Total Stock Market Index Fund531,0961.11%$9.94M0.00%Jun 30, 2026
Select Biotechnology Portfolio339,5000.71%$5.77M0.11%May 31, 2026
T. Rowe Price Health Sciences Fund, Inc.182,5470.38%$3.42M0.03%Jun 30, 2026
Vanguard Extended Market Index Fund179,6590.37%$3.36M0.00%Jun 30, 2026
Fidelity Growth Company K6 Fund164,6960.34%$2.80M0.01%May 31, 2026
Fidelity Series Growth Company Fund147,4000.31%$2.51M0.01%May 31, 2026
Franklin Biotechnology Discovery Fund99,8260.21%$1.89M0.16%Jul 31, 2026
Schwab Total Stock Market Index Fund15,0000.03%$283.95K0.00%Jul 31, 2026
Vanguard Russell 2000 Index Fund11,8830.02%$202.13K0.00%May 31, 2026
T. Rowe Price Health Sciences Portfolio11,2760.02%$210.97K0.03%Jun 30, 2026
Health Sciences Trust7,8990.02%$147.79K0.06%Jun 30, 2026
Blackstone Alternative Multi-Strategy Fund6,5750.01%$123.02K0.00%Jun 30, 2026
Vanguard Institutional Total Stock Market Index Fund6,4420.01%$120.53K0.00%Jun 30, 2026
EQ/T.Rowe Price Health Sciences Portfolio5,5710.01%$104.23K0.06%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Gary D. GlickSee Remarks, Director415,9730.87%May 11, 2026
Jason HaasChief Financial Officer62,9080.13%May 11, 2026
Natalie DalesSee Remarks36,8800.08%May 11, 2026
Anthony W. OpipariSee Remarks7,5060.02%May 11, 2026
Collin M. ToddSee Remarks––May 11, 2026
Jolie SiegelSee Remarks––May 7, 2026
Dimension Capital II, L.P.Director512,8621.07%May 12, 2026
Ian F. SmithDirector246,1000.51%May 11, 2026
Timothy P. WalbertDirector––May 11, 2026
Jeffrey M. LeidenDirector330,5400.69%May 11, 2026
Nan (LN) LiDirector3,333,5166.94%May 11, 2026
Ourania TatsisDirector––May 11, 2026
Valerie OdegardDirector––May 11, 2026
Shelley ChuDirector11,1110.02%May 11, 2026
Aranicki Ksenija PavleticDirector––May 7, 2026
Paulina HillDirector––May 7, 2026
Carolyn NgDirector0–May 7, 2026
Jon Winkelried–––May 13, 2026
Tpg Gp A, Llc–––May 13, 2026
James G. Coulter–3,690,1467.68%May 13, 2026
Sr One Capital Management, Llc10% owner––May 11, 2026
Simeon George10% owner2,376,9144.95%May 11, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
James G. Coulter
–
May 11, 2026Buy+1,388,889$18.00$25.00M3,690,146
James G. Coulter
–
May 11, 2026Conversion+1,880,497––2,301,257
James G. Coulter
–
May 11, 2026Other−2,351$18.00$42.32K420,760
James G. Coulter
–
May 11, 2026Other+423,111––423,111
Simeon George
10% owner
May 11, 2026Conversion+139,366––613,414
Simeon George
10% owner
May 11, 2026Sale−438$18.00$7.88K814,851
Simeon George
10% owner
May 11, 2026Option exercise+78,656––815,289
Simeon George
10% owner
May 11, 2026Conversion+273,527––736,633
Simeon George
10% owner
May 11, 2026Conversion+463,106––463,106
Simeon George
10% owner
May 11, 2026Buy+133,333$18.00$2.40M574,314
Simeon George
10% owner
May 11, 2026Sale−277$18.00$4.99K440,981
Simeon George
10% owner
May 11, 2026Option exercise+49,850––441,258
Simeon George
10% owner
May 11, 2026Conversion+166,168––391,408
Simeon George
10% owner
May 11, 2026Conversion+20,582––225,240
Simeon George
10% owner
May 11, 2026Conversion+204,658––204,658
Simeon George
10% owner
May 11, 2026Conversion+255,823––374,335
Simeon George
10% owner
May 11, 2026Conversion+118,512––118,512
Simeon George
10% owner
May 11, 2026Buy+222,222$18.00$4.00M1,831,383
Simeon George
10% owner
May 11, 2026Sale−1,065$18.00$19.17K1,609,161
Simeon George
10% owner
May 11, 2026Option exercise+191,541––1,610,226
Simeon George
10% owner
May 11, 2026Conversion+683,817––1,418,685
Simeon George
10% owner
May 11, 2026Conversion+61,762––734,868
Simeon George
10% owner
May 11, 2026Conversion+59,692––673,106
Simeon George
10% owner
May 11, 2026Buy+200,000$18.00$3.60M1,014,851
Simeon George
10% owner
May 11, 2026Conversion+474,048––474,048
Anthony W. Opipari
See Remarks
May 11, 2026Option exercise+541––7,506
Anthony W. Opipari
See Remarks
May 11, 2026Tax withholding−4$18.00$727,502
Anthony W. Opipari
See Remarks
May 11, 2026Conversion+6,965––6,965
Jeffrey M. Leiden
Director
May 11, 2026Conversion+28,698––28,698
Jeffrey M. Leiden
Director
May 11, 2026Tax withholding−17$18.00$30631,644
Jeffrey M. Leiden
Director
May 11, 2026Option exercise+2,963––31,661
Gary D. Glick
See Remarks, Director
May 11, 2026Conversion+27,386––415,973
Nan (LN) Li
Director
May 11, 2026Buy+1,111,111$18.00$20.00M3,333,516
Nan (LN) Li
Director
May 11, 2026Conversion+1,709,543––2,222,405
Shelley Chu
Director
May 11, 2026Buy+11,111$18.00$200.00K11,111
Dimension Capital II, L.P.
Director
May 8, 2026Buy+1,111,111$18.00$20.00M3,333,516
Dimension Capital II, L.P.
Director
May 8, 2026Conversion+1,709,543––2,222,405
Jeffrey M. Leiden
Director
May 8, 2026Buy+5,000$20.00$100.00K270,198
Jason Haas
Chief Financial Officer
May 8, 2026Buy+1,000$20.00$20.00K62,908

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
8.67%
3M shares short
Days to cover
15.4
At 0M shares a day
Change since last report
+2.0%
From 3M shares
Short volume, 20 days
73.2%
Of volume reported to FINRA

Shares sold short, last 6 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Odyssey Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 33,405 shares on Sep 21, 2026 over the last 90 days.

See a number that looks wrong?